ProQR Therapeutics (PRQR) Long-Term Investments (2019 - 2023)
ProQR Therapeutics' (PRQR) quarterly Long-Term Investments came in at $676222.0 in Q2 2023, up 2.05% year-on-year from $662642.2 in Q2 2022, and up 1.45% quarter-over-quarter from $666545.3 in Q1 2023.
ProQR Therapeutics (PRQR) Long-Term Investments (2019 - 2023) Analysis & Trends
ProQR Therapeutics has disclosed Long-Term Investments across 5 years of filings, most recently posting $676222.0 for Q2 2023.
- Long-Term Investments for Q2 2023 came in at $676222.0, up 2.05% year-over-year; the trailing twelve-month figure through Jun 2023 was $676222.0 (up 2.05% YoY), and the FY2022 annual result was $633573.6, up 6592.32% from the prior year.
- Long-Term Investments came in at $676222.0 for Q2 2023 at ProQR Therapeutics, up from $666545.3 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $784300.1 in Q2 2019 to a low of $749.07 in Q1 2021.
- The 5-year median for Long-Term Investments is $474854.8 (2019), against an average of $421193.4.
- Across the five-year window, Long-Term Investments slumped 99.77% in 2021 and surged 92944.61% in 2022, its largest moves.
- ProQR Therapeutics' Long-Term Investments stood at $474854.8 in 2019, then sank by 73.13% to $127575.0 in 2020, then tumbled by 92.83% to $9151.8 in 2021, then surged by 6822.96% to $633573.6 in 2022, then rose by 6.73% to $676222.0 in 2023.
- The last three Long-Term Investments figures came in at $676222.0 (Q2 2023), $666545.3 (Q1 2023), and $633573.6 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | ProQR Therapeutics | 7.27 Mn | -100.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 676,222.05 |
| Mar 31, 2023 | 666,545.27 |
| Dec 31, 2022 | 633,573.61 |
| Sep 30, 2022 | 626,138.36 |
| Jun 30, 2022 | 662,642.20 |
| Mar 31, 2022 | 696,971.72 |
| Dec 31, 2021 | 9,151.77 |
| Sep 30, 2021 | 108,494.43 |
| Jun 30, 2021 | 269,756.80 |
| Mar 31, 2021 | 749.07 |
| Dec 31, 2020 | 127,575.01 |
| Sep 30, 2020 | 185,724.28 |
| Jun 30, 2020 | 267,654.81 |
| Mar 31, 2020 | 325,662.01 |
| Dec 31, 2019 | 474,854.81 |
| Sep 30, 2019 | 644,270.69 |
| Jun 30, 2019 | 784,300.09 |